- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
Statutory Instruments
Public Health, England
Made
1st July 2020
Laid before Parliament
6th July 2020
Coming into force
1st October 2020
The Secretary of State makes these Regulations in exercise of the powers conferred by sections 45C(1), (2) and (3)(a), 45F(2)(a) and (b), 45P(2) and 60A of the Public Health (Control of Disease) Act 1984(1).
In accordance with section 45Q(3) of the Public Health (Control of Disease) Act 1984, the Secretary of State declares that in his opinion these Regulations do not contain any provision made by virtue of section 45C(3)(c) of that Act which imposes or enables the imposition of a special restriction or requirement, or any other restriction or requirement which has or would have a significant effect on a person’s rights.
1. These Regulations may be cited as the Health Protection (Notification) (Amendment) (No. 2) Regulations 2020 and come into force on 1st October 2020.
2.—(1) The Health Protection (Notification) Regulations 2010(2) are amended as follows.
(2) In regulation 4 (duty to notify causative agents found in human samples), after paragraph (2)(d) insert—
“(da)the results of any antimicrobial susceptibility test and any resistance mechanism identified in respect of the sample;”.
(3) In Schedule 2 (causative agents), at the appropriate place insert—
“Acquired carbapenemase-producing Gram-negative bacteria”.
Signed by the authority of the Secretary of State for Health and Social Care
James Bethell
Parliamentary Under Secretary of State,
Department of Health and Social Care
1st July 2020
(This note is not part of the Regulations)
These Regulations amend the Health Protection (Notification) Regulations 2010 (S.I. 2010/659).
Regulation 2(2) adds to the information required to be included in the notification of a causative agent to Public Health England the results of any antimicrobial susceptibility test and any resistance mechanism identified in respect of the sample. Regulation 2(3) adds Acquired carbapenemase-producing Gram-negative bacteria to the list of causative agents in Schedule 2.
A full impact assessment has not been produced for this instrument because no, or no significant, impact on the private, voluntary or public sectors is foreseen. An Explanatory Memorandum has been published alongside these Regulations on www.legislation.gov.uk.
1984 c.22; sections 45C, 45F and 45P were inserted by section 129 of the Health and Social Care Act 2008 (c.14).
S.I.2010/659, amended by S.I. 2020/237; there are other amending instruments but none is relevant.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: